DataSheet_1_Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium.xlsx
Major Histocompatibility Complex (MHC)-I and -II genes are upregulated in intestinal epithelial cells (IECs) during active inflammatory bowel diseases (IBD), but little is known about how IBD-relevant pro-inflammatory signals and IBD drugs can regulate their expression. We have previously shown that the synthetic analog of double-stranded RNA (dsRNA) Polyinosinic:polycytidylic acid (Poly(I:C)), induces interferon stimulated genes (ISGs) in colon organoids (colonoids). These ISGs may be involved in the induction of antigen presentation. In the present study, we applied colonoids derived from non-IBD controls and ulcerative colitis patients to identify induction and effects of IBD-drugs on antigen presentation in IECs in the context of Tumor Necrosis Factor (TNF)-driven inflammation. By RNA sequencing, we show that a combination of TNF and Poly(I:C) strongly induced antigen-presentation gene signatures in colonoids, including expression of MHC-II genes. MHC-I and -II protein expression was confirmed by immunoblotting and immunofluorescence. TNF+Poly(I:C)-dependent upregulation of MHC-II expression was associated with increased expression of Janus Kinases JAK1/2 as well as increased activation of transcription factor Signal transducer and activator of transcription 1 (STAT1). Accordingly, pre-treatment of colonoids with IBD-approved pan-Janus Kinase (JAK) inhibitor Tofacitinib led to the downregulation of TNF+Poly(I:C)-dependent MHC-II expression associated with the abrogation of STAT1 activation. Pre-treatment with corticosteroid Budesonide, commonly used in IBD, did not alter MHC-II expression. Collectively, our results identify a regulatory role for IBD-relevant pro-inflammatory signals on MHC-II expression that is influenced by Tofacitinib.
History
References
- https://doi.org//10.1016/j.jcmgh.2017.03.007
- https://doi.org//10.1038/nri3608
- https://doi.org//10.1093/ibd/izz075
- https://doi.org//10.3389/fimmu.2018.02144
- https://doi.org//10.1111/imm.13270
- https://doi.org//10.1038/354392a0
- https://doi.org//10.1073/pnas.85.11.3975
- https://doi.org//10.1038/375802a0
- https://doi.org//10.1016/0092-8674(95)90061-6
- https://doi.org//10.1016/1074-7613(95)90089-6
- https://doi.org//10.1016/j.cell.2018.10.008
- https://doi.org//10.1136/gut.33.8.1089
- https://doi.org//10.1084/jem.20201665
- https://doi.org//10.1371/journal.pone.0265189
- https://doi.org//10.1620/tjem.165.87
- https://doi.org//10.3389/fimmu.2019.01970
- https://doi.org//10.1371/journal.pone.0086844
- https://doi.org//10.1093/ibd/izaa145
- https://doi.org//10.1046/j.1365-2249.2001.01443.x
- https://doi.org//10.1016/S1074-7613(00)80468-9
- https://doi.org//10.1016/j.immuni.2019.08.011
- https://doi.org//10.1016/j.stem.2021.08.007
- https://doi.org//10.3390/ijms221910851
- https://doi.org//10.1097/01.MIB.0000480300.78972.da
- https://doi.org//10.1093/ecco-jcc/jjaa022
- https://doi.org//10.3389/fphar.2019.00212
- https://doi.org//10.1093/ecco-jcc/jjx003
- https://doi.org//10.1093/ecco-jcc/jjaa075
- https://doi.org//10.1093/ibd/izaa157
- https://doi.org//10.1056/NEJMoa1112168
- https://doi.org//10.1056/NEJMoa1606910
- https://doi.org//10.1111/apt.15555
- https://doi.org//10.1136/annrheumdis-2013-203756
- https://doi.org//10.1093/ibd/izz266
- https://doi.org//10.1016/j.celrep.2021.109916
- https://doi.org//10.1016/j.jcmgh.2015.01.006
- https://doi.org//10.3791/52483
- https://doi.org//10.1136/gutjnl-2016-313667
- https://doi.org//10.1053/j.gastro.2011.07.050
- https://doi.org//10.3389/fphar.2021.679741
- https://doi.org//10.1371/journal.pone.0056818
- https://doi.org//10.1038/nm.2470
- https://doi.org//10.1038/nmeth.2019
- https://doi.org//10.1111/cei.12047
- https://doi.org//10.1136/ard.2011.150284
- https://doi.org//10.1111/1759-7714.13847
- https://doi.org//10.1038/s41375-018-0123-z
- https://doi.org//10.1038/ncomms9642
- https://doi.org//10.1371/journal.ppat.1008558
- https://doi.org//10.1136/gutjnl-2016-312609
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity